Guillén, David <br/><br/>
Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.  [electronic resource] 

 -  Molecular diagnosis & therapy  Dec 2010 
 - 357-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-2000 
<br/><br/><label>Standard No.: </label>10.1007/BF03256393  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Adult<br/>Aged<br/>Atorvastatin<br/>Biomarkers--analysis<br/>Cell Proliferation--drug effects<br/>Culture Media, Conditioned--analysis<br/>Cytokines--analysis<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Heptanoic Acids--blood<br/>Humans<br/>Hypercholesterolemia--drug therapy<br/>Immunosuppressive Agents--pharmacology<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Pyrroles--blood<br/>T-Lymphocyte Subsets--drug effects<br/>T-Lymphocytes, Regulatory--drug effects<br/>Tacrolimus--pharmacology<br/>Transplantation